Literature DB >> 11901086

Atypical kinetic profiles in drug metabolism reactions.

J Matthew Hutzler1, Timothy S Tracy.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11901086     DOI: 10.1124/dmd.30.4.355

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  61 in total

1.  UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP.

Authors:  Wen Jiang; Beibei Xu; Baojian Wu; Rong Yu; Ming Hu
Journal:  Drug Metab Dispos       Date:  2011-11-09       Impact factor: 3.922

2.  Drug-drug interaction potential of marketed oncology drugs: in vitro assessment of time-dependent cytochrome P450 inhibition, reactive metabolite formation and drug-drug interaction prediction.

Authors:  Jane R Kenny; Sophie Mukadam; Chenghong Zhang; Suzanne Tay; Carol Collins; Aleksandra Galetin; S Cyrus Khojasteh
Journal:  Pharm Res       Date:  2012-03-14       Impact factor: 4.200

3.  Sulfation of ractopamine and salbutamol by the human cytosolic sulfotransferases.

Authors:  Kyounga Ko; Katsuhisa Kurogi; Garrett Davidson; Ming-Yih Liu; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  J Biochem       Date:  2012-07-04       Impact factor: 3.387

4.  Inhibition of Sodium-Hydrogen Antiport by Antibodies to NHA1 in Brush Border Membrane Vesicles from Whole Aedes aegypti Larvae.

Authors:  Kenneth M Sterling; William R Harvey
Journal:  J Membr Biol       Date:  2018-11-03       Impact factor: 1.843

5.  Line-walking method for predicting the inhibition of P450 drug metabolism.

Authors:  Matthew G Hudelson; Jeffrey P Jones
Journal:  J Med Chem       Date:  2006-07-13       Impact factor: 7.446

Review 6.  In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.

Authors:  Stephen Fowler; Hongjian Zhang
Journal:  AAPS J       Date:  2008-08-07       Impact factor: 4.009

7.  Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency.

Authors:  Vanja Polic; Irina F Sevrioukova; Karine Auclair
Journal:  Arch Biochem Biophys       Date:  2018-06-26       Impact factor: 4.013

8.  Breast cancer resistance protein-mediated efflux of luteolin glucuronides in HeLa cells overexpressing UDP-glucuronosyltransferase 1A9.

Authors:  Lan Tang; Ye Li; Wei-Ying Chen; Shan Zeng; Ling-Na Dong; Xiao-Juan Peng; Wen Jiang; Ming Hu; Zhong-Qiu Liu
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

9.  Magic-angle spinning solid-state NMR spectroscopy of nanodisc-embedded human CYP3A4.

Authors:  Aleksandra Z Kijac; Ying Li; Stephen G Sligar; Chad M Rienstra
Journal:  Biochemistry       Date:  2007-11-07       Impact factor: 3.162

10.  Cooperative effects on radical recombination in CYP3A4-catalyzed oxidation of the radical clock beta-thujone.

Authors:  Yongying Jiang; Paul R Ortiz de Montellano
Journal:  Chembiochem       Date:  2009-03-02       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.